European federation of societies for ultrasound in medicine and biology (EFSUMB) guidelines for the use of contrast agents in liver ultrasound: What is the impact in clinical practice?

European Radiology, Supplement

Volumn 15, Issue 5, 2005, Pages

  Lencioni, Riccardo ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Liver neoplasms; Liver neoplasms, diagnosis; Ultrasound,contrast agents

Indexed keywords

CONTRAST MEDIUM;

ARTICLE; BENIGN TUMOR; CANCER PATIENT; CLINICAL PRACTICE; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; EUROPE; FOLLOW UP; HEPATOGRAPHY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER METASTASIS; LIVER NODULE; LIVER TUMOR; MALIGNANT NEOPLASTIC DISEASE; MEDICAL SOCIETY; MICROBUBBLE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; REPRODUCIBILITY; SENSITIVITY ANALYSIS;

CONTRAST MEDIA; EUROPE; HUMANS; LIVER DISEASES; PRACTICE GUIDELINES AS TOPIC; ULTRASONOGRAPHY;

EID: 33644609009     PISSN: 16133749     EISSN: 16133757     Source Type: Journal    
DOI: 10.1007/s10406-005-0171-0     Document Type: Article

References (10)

1. Lencioni R, Cioni D, Bartolozzi C (2002) Tissue harmonic and contrast-specific imaging: Back to grey scale in ultrasound. Eur Radiol 12:151-165
2. Lencioni R, Cioni D, Crocetti L et al (2002) Ultrasound imaging of focal liver lesions with a second-generation contrast agent. Acad Radiol 9 [Suppl 2]:S371-374
3. Albrecht T, Blomley M, Bolondi L et al (2004) EFSUMB Study Group 2004. Guidelines for the use of contrast agents in ultrasound. Ultraschall Med 25:249-256
4. Quaia E, Calliada F, Bertolotto M et al (2004) Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: Diagnostic performance and confidence. Radiology 232:420-430
5. Bruix J, Sherman M, Llovet JM et al (2001) EASL Panel of Experts on HCC Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421-430
6. Gaiani S, Celli N, Piscaglia F et al (2004) Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol 41:421-426
7. Nicolau C, Catala V, Vilana R et al (2004) Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 14:1092-1099
8. Solbiati L, Livraghi T, Goldberg SN et al (2001) Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221:159-166
9. Lencioni R, Crocetti L, Cioni D et al (2004) Percutaneous radiofrequency ablation of hepatic colorectal metastases. Technique, indications, results, and new promises. Invest Radiol 39:689-697
10. Lencioni R, Cioni D, Crocetti L et al (2005) Early-stage hepatocellular carcinoma in cirrhosis: Long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961-967